Genetic Discussions in Oncology Nursing

Video

There is an expanding role for oncology nurses in the field of cancer genetics, explained Sue Friedman, the founder and executive director of Facing Our Risk of Cancer Empowered (FORCE).

Friedman personally had genetic counseling with an oncology nurse, and said that it is important for all nurses to be aware of genetic testing and which cancers are associated with mutations, so that they can have key conversations with their patients.

Related Videos
Meaghan Mooney, B.S.N., RN, OCN, during the Extraordinary Healer interview
Colleen O’Leary, DNP, RN, AOCNS, EBP-C, LSSYB, in an interview with Oncology Nursing News.
Michelle H. Johann, DNP, RN, PHN, CPAN, WTA, in an interview with Oncology Nursing News explaining surgical path cards
Alison Tray, of Hartford Healthcare, discusses her team's research on a multidisciplinary team approach to manage the cancer drug shortage
Related Content
dna genetics genomic tests © marina zlochin -adobe.stock.com.png

Out-of-Pocket Costs, Insurance Status May Impact Genomic Testing Rates

April 10th 2024
Article

Genetic testing decisions in patients with cancer may be affected by significant out-of-pocket costs.

lung cancer

Should You Wait for NGS Results Before Initiating NSCLC Treatment?

November 17th 2023
Article

Beth Sandy, MSN, CRNP, and Tajuana Bradley, MSN, APRN-BC, discuss the importance of molecular testing in non–small cell lung cancer.

Are At-Home Genomic Tests Such as 23andMe Ethical?

Are At-Home Genomic Tests Such as 23andMe Ethical?

September 22nd 2023
Article

Cheryl VerStrate, DNP, AGPCNP-BC, OCN, explains the pitfalls with at-home genomic tests and why nurses must be ready to talk to their patients about genetic counseling.

nurse with patient

Increase in Direct-to-Consumer Genomic Testing Yields New Ethical Considerations for Oncology Nurses

August 10th 2023
Article

Oncology nurses make the case for nurse intervention with direct-to-consumer genomic testing.

DNA

Oncology Nurses Play a Vital Role in Fostering Biomarker Testing Conversations With Patients

April 28th 2023
Article

Julie C. Martin DNP, AOCN, FNP-BC, discusses best practices to approaching conversations on clinically actionable genomic results with patients.

DNA Helix

CDCT1 Testing Study Highlights Pitfalls in Current NCCN Genetic Condition Screening Guidelines

April 18th 2023
Article

Findings from the TAPESTRY trial showed that approximately 40% of patients with genetic conditions may be missed by current NCCN guidelines.

© 2024 MJH Life Sciences

All rights reserved.